Pre-Series AHealthTech

Vytalyou | ₹9 Cr / ~$1M (Pre-Series A)

Investorsync desk1 min read

Deal sheet

₹9 Cr

Stage
Pre-Series A
Sector
HealthTech
Announced
30 September 2026

Founders: DR. CHIRANTAN BOSE, Dr. Preetesh Bhandari

Founded: 2025

HQ: Mumbai

Sector: Preventive Healthcare / Longevity

What they do

→ Doctor-led longevity and preventive healthcare clinics combining diagnostics, personalised interventions, and medically supervised care

→ Services span pathology, radiology, cardio-respiratory assessment, genetic/cancer screening, gut microbiome evaluation, IV therapies, and regenerative treatments

→ Uses an AI-based Predictive Longevity Evaluation to assess biological ageing and health risks, with doctors reviewing every plan

→ Has served ~1,000 clients since opening its first centre in Powai

The Funding

→ Raised ₹9 Cr in pre-Series A

→ From Chetan Jain (Pharma Dose) and Ratan Jain (Venus Industries)

→ Values Vytalyou at ~₹33 Cr

Why it matters

→ Will expand to Juhu and Worli, taking its Mumbai network to 3 centres, with 10 locations planned nationally

→ India's longevity-care segment is reportedly growing 30%+ annually, with some estimates over 50%

→ Joins a heating-up category alongside Biopeak, Cent, Elevate Now, and Decode Age

→ Founders bring specialist medical credibility (molecular oncology, radiology) rather than a pure wellness-brand angle

Is "longevity medicine" a real category in India, or just premium health check-ups rebranded?

Source: company announcement. First posted on the Investorsync LinkedIn page.

Keep reading

The Sync Report

All Rounds